Refine by
Industries served
- Medical / Health Care
- Monitoring and Testing
- Agriculture
- Chemical & Pharmaceuticals
- Environmental
- Health and Safety
- University / Academia / Research
- Waste and Recycling
- Water and Wastewater
- Air and Climate
- Mining
- Automobile & Ground Transport
- Domestic
- Retail
- Logistics
- Soil and Groundwater
- Manufacturing, Other
- Food and Beverage
- Energy
Disease Detection Suppliers Serving Norway
99 companies found
based inNotting Hill, AUSTRALIA
INOVIQ Ltd (ASX:IIQ) (INOVIQ) is developing and commercialising an innovative portfolio of diagnostic and exosome-based solutions for the earlier detection, diagnosis, prognosis and monitoring of cancer and other diseases to improve patient outcomes ...
based inRockville, MARYLAND (USA)
20/20 GeneSystems (“20/20”) is focused on on reducing cancer deaths worldwide through its years of experience in the development and use of cancer biomarker test development. By leveraging this expertise and combining it with advanced machine ...
20/20 GeneSystems developed PAULA’s Test, a blood test for early detection of lung cancer. It is available in the USA through licensed medical professionals. Testing is performed at 20/20’s CLIA licensed laboratory, Genesys Biolabs (CLIA ...
based inGurgaon (Delhi NCR), INDIA
Incorporated in the Year 2010, Quy Technology Pvt Ltd provides bespoke Mobile app development services. Quytech has expertise in niche technology services on mobile application development, consulting and outsourcing. We believe in processing the ...
AI Recommendation engines today play an important role in helping businesses and customers have a better user experience. Product recommendations, movie suggestions, and people whom you would like to know on social media platforms are some of the ...
based inMainz, GERMANY
Fuelled by Innovation: With a pioneering spirit and high technical expertise, ORGENTEC has become firmly established in medical diagnostics. Our employees’ talent and skills establish the basis for our success. At our headquarters in Mainz, Germany, ...
AMA-M2 is an ELISA-based, automated, in-vitro test system for the quantitative determination of IgG antibodies against mitochondrial M2 subtype antigen in human serum or plasma. Anti-mitochondrial antibodies (AMA) are a heterogeneous group of ...
based inNeulichtenberg, AUSTRIA
Surgebright has specialized in supplying clinics with human bone replacement material ( allogeneic bone replacement ). Whether spongiosa chips, femoral heads or bone screws, surgebright only supplies bone replacement material made from allogeneic, ...
As a certified Austrian tissue bank , surgebright meets the highest quality standards. Regular audits by AGES, our partners and surgebright itself ensure that all regulatory requirements are met. Through our cooperation with large international ...
based in, ONTARIO (CANADA)
Labex Canada Inc. was established as a federally registered company in 2011 in Halifax, Nova Scotia, Canada. In 2015 a new facility was opened in Newmarket, Ontario, Canada. Since the beginning the company has been active in import/export/marketing ...
In humans, they are known to be involved mainly in respiratory infections ranging from the common colds to more severe diseases such as Middle East Respiratory Syndrome (MERS) and Severe Acute Respiratory Syndrome (SARS). The ...
based inSyracuse, NEW YORK (USA)
Mesothelioma is an aggressive cancer that affects the lining of the lungs, heart, or abdomen. Caused by the inhalation of asbestos fibers, mesothelioma is often diagnosed in older individuals who worked with asbestos products. Prognosis for ...
based inSan Diego, CALIFORNIA (USA)
Nucleix is a liquid biopsy company revolutionizing cancer treatment with earlier disease detection, at a time when intervention can bring the greatest impact for patients. Leveraging PCR-based epigenetics, our pioneering testing approach uses ...
Most patients are currently diagnosed with late-stage cancer, though research has shown 5-year survival rates are up to 10 times greater when disease is detected early. Annual imaging (low-dose CT scans) is ...
based inSanta Clara, CALIFORNIA (USA)
For more than 40 years, Agilent Technologies has been the leading provider of solutions for the detection, identification, and characterization of chemical and biological compounds. From environmental testing to semiconductor manufacturing, ...
based inBoca Raton, FLORIDA (USA)
Entero Therapeutics is a clinical-stage biopharmaceutical company dedicated to developing targeted, orally delivered therapies for gastrointestinal (GI) diseases. At the core of its research are three proprietary technologies. Latiglutenase is an ...
A majority of individuals with CD do not recover well under a GFD. Furthermore, there is still no effective means for monitoring the intestinal health of a recovering celiac other than an invasive biopsy and even that method is prone to interpretive ...
based inNottingham, UNITED KINGDOM
Oncimmune is a leading immuno diagnostics developer, primarily focused on the growing fields of immuno-oncology, autoimmune disease and infectious diseases. Our growing range of diagnostic products can detect early-stage cancer and our service-based ...
based inAarhus C, DENMARK
Cercare Medical is based on +25 years of research in perfusion imaging and artificial intelligence. Our novel biomarkers provide unparalleled patient insights. We are bridging the gap between science and clinical practice. With our amazing ...
based inManassas, VIRGINIA (USA)
Notal Vision is the first diagnostic services company to extend eye disease management from the clinic to the home and improve vision outcomes. By applying artificial intelligence (AI)-driven data interpretation to the unprecedented high volumes of ...
based inWest Lafayette, INDIANA (USA)
Tymora Analytical Operations provides diagnostic development and exosome proteomics contract services and products for improved cancer research. Tymora’s primary goal is to enable the shift from tissue to liquid biopsy. Our new technologies allow ...
based inVillejuif, FRANCE
Stilla Technologies is the multiplex digital PCR company transforming complex genomic data into actionable insights across a wide range of research and clinical applications including cancer and liquid biopsy studies, cell and gene therapies, ...
based inAustin, TEXAS (USA)
Natera is a global leader in cell-free DNA (cfDNA) testing, dedicated to oncology, women’s health, and organ health. We aim to make personalized genetic testing and diagnostics part of the standard of care to protect health and inform earlier, more ...
Signatera is a personalized, tumor-informed assay optimized to detect circulating tumor DNA (ctDNA) for molecular residual disease (MRD) assessment and recurrence monitoring for patients previously diagnosed with ...
based inHeidelberg, GERMANY
Hummingbird is harnessing the predictive power of blood-borne miRNAs to provide insights into human health and disease. Analysis of miRNAs with Hummingbird’s platform holds the potential for early disease detection, disease-specific prognostics, ...
Non-invasive sample sources as key for early disease detection & therapeutic monitoring body fluids, including whole blood, serum, plasma, CSF, urine optimized and validated ...
based inChicago, ILLINOIS (USA)
Igenbio, Inc. develops genome analysis products and services for the life science industry. Our scientists have broad experience in both in silico and wet lab sequencing, research and development with more than 100 relevant publications in these ...
based inRedwood City, CALIFORNIA (USA)
Guardant Health is a leading precision oncology company dedicated to helping conquer cancer through our proprietary blood tests, vast data sets, and advanced analytics. We’re developing blood tests for early detection in high-risk populations and ...
Our Guardant Reveal™ test is the first blood-only test that detects residual and recurrent disease in two weeks, without the need for a tissue biopsy. The test detects circulating tumor DNA ...
based inConcepción, CHILE
We are a Chilean biotech company that enables the availability of products and services that improve the quality of life for humans and animals worldwide. We have a team of professionals with over 12 years experience in development of applied ...
AHPND has a bacterial aetiology. It is caused by specific virulent strains of Vibrio parahaemolyticus. Acute hepatopancreatic necrosis disease (AHPND) is a serious disease that has caused severe damage and significant financial losses to the global ...